Novo Nordisk is working on a new obesity drug that could help patients shed ... could reignite Novo shares. Semaglutide ...
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...
Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all ...
Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...